Hiroshima University Hospital

Futó vizsgálatok

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  NCT07541170· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.

  NCT07734116· 1/2. fázis· Ono Pharmaceutical Co., Ltd.· Forrás

• Toboroz

  A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer

  NCT07766018· 2. fázis· Stemline Therapeutics, Inc.· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Pancreatic Cancer Screening Using the Enzeavour Assay in Japan

  NCT07605819· Cosomil, Inc.· Forrás

• Toboroz

  A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

  NCT07219212· 1. fázis· Johnson & Johnson Enterprise Innovation Inc.· Forrás

• Toboroz

  Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  NCT07195695· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  NCT07174336· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

  NCT07128199· 3. fázis· Taiho Oncology, Inc.· Forrás

• Toboroz

  A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

  NCT07218146· 3. fázis· Zai Lab (Shanghai) Co., Ltd.· Forrás

• Toboroz

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis

  NCT07136116· AbbVie· Forrás

• Toboroz

  A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  NCT07196722· 2/3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  NCT06963827· 3. fázis· Takeda· Forrás

• Toboroz

  Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer

  NCT06976944· 2. fázis· Yukinori Ozaki· Forrás

• Toboroz

  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  NCT06925737· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  NCT06790693· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  NCT06644781· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

  NCT06585774· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  NCT06712316· 2/3. fázis· BioNTech SE· Forrás

• Toboroz

  A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

  NCT06699212· 3. fázis· Rakuten Medical, Inc.· Forrás

• Fut, nem toboroz

  Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

  NCT06635824· 3. fázis· Genmab· Forrás

• Toboroz

  Study to ONO-4538 in Patients With Rhabdoid Tumor

  NCT06622941· 2. fázis· Ono Pharmaceutical Co., Ltd.· Forrás

• Toboroz

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

  NCT06623422· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  NCT06598943· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

  NCT06510374· 3. fázis· Ferring Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

  NCT06558279· 3. fázis· argenx· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease

  NCT06263478· 3. fázis· Incyte Biosciences Japan GK· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  NCT06430801· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  NCT06312137· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis

  NCT06260709· 2. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.

  NCT05930275· AbbVie· Forrás

• Fut, nem toboroz

  A Study of KK2269 in Adult Participants With Solid Tumors

  NCT06266299· 1. fázis· Kyowa Kirin Co., Ltd.· Forrás

• Toboroz

  Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  NCT06136624· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

  NCT06077760· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors

  NCT06248411· 1. fázis· Kyowa Kirin Co., Ltd.· Forrás

• Fut, nem toboroz

  Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

  NCT05899608· 3. fázis· Summit Therapeutics· Forrás

• Fut, nem toboroz

  A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

  NCT06052059· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  NCT05879926· 3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

  NCT05904886· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

  NCT05797610· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

  NCT05843643· 3. fázis· AbbVie· Forrás

• Toboroz

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  NCT05716100· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás

• Meghívásos bevonás

  A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT05735483· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

  NCT05327894· 3. fázis· Princess Maxima Center for Pediatric Oncology· Forrás

• Fut, nem toboroz

  A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

  NCT05648500· 3. fázis· Viatris Innovation GmbH· Forrás

Showing 50 of 95.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák9 toboroz
• Fej-nyaki daganatok4 toboroz
• Gyermekkori daganatok4 toboroz
• Áttétes emlőrák3 toboroz
• Crohn-betegség3 toboroz
• Zsírmáj (MASLD/MASH)3 toboroz
• Colitis ulcerosa2 toboroz
• Epilepszia2 toboroz
• Liver cirrhosis2 toboroz
• Petefészekrák2 toboroz
• Prosztatarák2 toboroz
• Szarkóma2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hólyagrák1 toboroz
• IgA-nefropátia1 toboroz
• Lupus (SLE)1 toboroz
• Myasthenia gravis1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  An Exploratory Study of MT-2990 in Patients With AAV

  NCT06196905· 1. fázis· Tanabe Pharma Corporation· Forrás

• Toboroz

  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  NCT06136650· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan

  NCT05791526· AbbVie· Forrás

• Lezárult

  A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

  NCT05174221· 1. fázis· Takeda· Forrás

• Lezárult

  A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

  NCT05442047· 2. fázis· Novo Nordisk A/S· Forrás

• Leállították

  A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.

  NCT05322577· 1/2. fázis· Amgen· Forrás

• Lezárult

  Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

  NCT05399329· Pfizer· Forrás

• Lezárult

  The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

  NCT05162586· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)

  NCT05084053· 3. fázis· Takeda· Forrás

• Lezárult

  Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

  NCT05142722· 3. fázis· NewAmsterdam Pharma· Forrás

• Lezárult

  A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

  NCT05029895· AbbVie· Forrás

• Lezárult

  Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)

  NCT04740307· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer

  NCT04619797· 2/3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

  NCT04543617· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

  NCT04439539· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

  NCT04423718· 3. fázis· Bayer· Forrás

• Lezárult

  A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

  NCT04435600· 3. fázis· AbbVie· Forrás

• Lezárult

  Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection

  NCT04457297· 3. fázis· National Cancer Center Hospital East· Forrás

• Lezárult

  Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

  NCT04303780· 3. fázis· Amgen· Forrás

• Lezárult

  Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

  NCT04340115· AbbVie· Forrás

• Lezárult

  Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

  NCT03938792· 3. fázis· Pfizer· Forrás

• Lezárult

  A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)

  NCT04199104· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

  NCT04102098· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

  NCT04083976· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

  NCT04034095· Janssen Pharmaceutical K.K.· Forrás

• Lezárult

  Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

  NCT03867084· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

  NCT03713593· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

  NCT03783442· 3. fázis· BeiGene· Forrás

• Lezárult

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

  NCT03456063· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

  NCT03358472· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma

  NCT03274492· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

  NCT03040999· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

  NCT03025308· 3. fázis· Alfasigma S.p.A.· Forrás

• Lezárult

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· 3. fázis· Alfasigma S.p.A.· Forrás

• Lezárult

  Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease

  NCT02906488· AbbVie· Forrás

• Lezárult

  Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III

  NCT02761070· 3. fázis· Kyorin University· Forrás

• Lezárult

  Cryo Global Registry

  NCT02752737· Medtronic Cardiac Ablation Solutions· Forrás

• Lezárult

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· 3. fázis· Takeda· Forrás

• Lezárult

  Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

  NCT02486718· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

  NCT02273375· 3. fázis· Canadian Cancer Trials Group· Forrás

• Lezárult

  Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

  NCT00980460· 3. fázis· National Cancer Institute (NCI)· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Rheumatoid arthritis21 munka · 2 vizsgálat
• ANCA-asszociált vasculitis8 munka · 1 vizsgálat
• Hemofília8 munka · 3 vizsgálat